POLE-END REAL LIFE: Endometrial Cancer Early Stages I-II and Advanced Stages III and IV Evaluation of POLE as a Prognostic Factor. Participants Are Women >= 18 Years Old, With the Pole Mutation
Clinical trial NCT06409039 · UNKNOWN
Trial details
- NCT number
- NCT06409039
- Sponsor
- Azienda Ulss 2 Marca Trevigiana
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-09-04
- Primary completion
- 2024-03-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.